(adapted from: national academy of sciences -national ... · pdf file• human...
TRANSCRIPT
CHARACTERIZATION OF HUMAN HEALTH EFFECTS
ELEMENTS CONSIDERED IN HOST CHARACTERIZATION
(previous lecture)• Age
• Immune status
• Concurrent illness or infirmity
• Genetic background
• Pregnancy
• Nutritional status
• Demographics of the exposed population
(density, etc.)
• Social and behavioral traits
CHARACTERIZATION OF HUMAN HEALTH EFFECTS
ELEMENTS CONSIDERED IN HEALTH EFFECTS
(previous lecture)
• Duration of illness
• Severity of illness
• Infectivity
• Morbidity, mortality, sequelae of illness
• Extent or amount of secondary spread
• Quality of life
• Chronicity or recurrence
Characteristics or Properties of Pathogens
Interactions with Hosts (previous lecture)
• Disease characteristics and spectrum
• Persistence in hosts:
– Chronicity
– Persistence
– Recrudescence
– Sequelae and other post-infection health
effects• cancer, heart disease, arthritis,
neurological effects• Secondary spread
Epidemiology in Microbial Risk Analysis
• Problem Formulation: What’s the problem? Determine what infectious disease is posing a risk, its clinical features, causative agent, routes of exposure/infection and health effects
• Exposure Assessment: How, how much, when, where and why exposure occurs; vehicles, vectors, doses, loads, etc.
• Health Effects Assessment:
– Human clinical trials for dose-response
– field studies of endemic and epidemic disease in populations
• Risk characterization: Epidemiologic measurements and analyses of risk: relative risk, risk ratios, odds ratios; regression models of disease risk; dynamic model of disease risk– other disease burden characterizations: relative contribution tooverall disease burdens; effects of prevention and control measures; economic considerations (monetary cost of the disease and cost effectiveness of prevention and control measures
Approaches to Risk Estimation
• Direct approach: The intervention trial
– Can be used to assess risk from drinking water and
recreational water exposures
– Problems with sensitivity (sample size issue)
– Trials can are expensive (esp. in developed countries)
• Indirect approach: Mathematical models
– Must account for properties of infectious disease
processes
– Pathogen specific models
– Uncertainty and variability may make interpretation
difficult.
Elements That May be Included in Dose-Response Analysis
• Statistical model(s) to analyze of quantify dose-
response relationships
• Human dose-response data
• Animal dose-response data
• Utilization of outbreak or intervention data
• Route of exposure or administration
• Source and preparation of challenge material or
inoculum
• Organism type and strain– including virulence factors or other measures of pathogenicity
• Characteristics of the exposed population– age, immune status, etc.
• Duration and multiplicity of exposure
Dose-Response Data
and Probability of Infection for Human Rotavirus
Dose # Dosed # Infected90,000 3 39,000 7 5900 8 790 7 69 7 10.9 7 00.09 5 0
Dose-Response Models and Extrapolation to Low Dose Range
• Most dose-response data for microbes are for high
doses of microbes and few hosts
– due practicalities and cost limits
• Real-world exposures to microbes from water, food
and air are often to much lower microbial doses
• One must extrapolate the dose-response
relationship to the low dose range where there are
no experimental data points
– a best-fit modelling approach is employed
Models Typically Applied in Microbial Dose-Response Analyses
• Exponential model: Pinfection = 1 – e -rµ
where r = probability of infection and µ = mean concentration/dose
– assumes organisms are distributed randomly (Poisson) and
– probability of infection = r
– approaches a linear model at low doses
• Exponential (linear) model; two populations:
– one-hit kinetics, but
– two classes of human susceptibility to microbe
• Beta-Poisson: a distributed threshold model
– assumes Poisson distribution of microbes and a Beta-
distributed probability of infection • r is not a constant but a probability distribution (Beta-distribution)
– two variables in the model
Probabilities of Exposure and Infection
• Pexp (j Dose) = Probability of having j pathogenic microbes in an ingested dose
• Pinf (j Inf) = Conditional probability of infection from j pathogens ingested
Daily and Annual Risks of Various Outcomes from Exposure to Water
Containing 4 Rotaviruses per 1000 Liters
Volunteer Dose-Response Data for Norwalk Virus*
Dose (ml) No. Dosed No Ill % Ill
4 16 11 69
1 21 14 67
0.01 4 2 50
0.0001 4 0 0
*"1st passage NV": Dolin et al. 1972; Wyatt et al., 1974.
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.0001 0.01 1 4
Dose (ml)
P(D
) F
ract
ion
wit
h E
ffe
ct Measured
Linear (exp)
Lin (2pop)
b-Poisson
Norwalk Virus Dose-Response Analysis Using Alternative Models
Dose-Response Relationships for Various
Waterborne Pathogens: Downward Extrapolation
to Low-Dose Range
Approaches for Risk Estimation: Risk Assessment Model Model
Cryptosporidium Giardia Viruses
1. Source water
Concentration (organisms per liter) (Normal Mean (SD)*)
1.06 (2.24)
2.68 (24.20)
0.93 (3.00)
Recovery rate 0.40 0.40 0.48
2. Treatment efficiency (logs removal)
Sedimentation and filtration (Mean (SD)*)
3.84 (0.59)
3.84 (0.59)
1.99 (0.52)
Chlorination (Mean (SD)
0 3.5 (2.93) 4 (2.93)
3. Water Consumption
in liters (mean (SD) ‡)
0.094 (0.42)
0.094 (0.42)
0.094 (0.42)
4. Dose Response § λ: 0.004078 λ:
0.01982 α,β: 0.26, 0.42
5. Morbidity Ratio# 0.39 0.40 0.57
Databases for Quantification and Statistical
Assessment of Disease
• National Notifiable Disease Surveillance
System
• National Ambulatory Medical Care Survey
• International Classification of Disease
(ICD) Codes
• Other Databases
– Special surveys
– Sentinel surveillance efforts
Infectious Disease Transmission (SIR) Model:
Host States in Relation to Pathogen Transmission
Susceptible Infected Resistantβ β β
Pathogen
Exposure
β = the rate or probability of movement from one state to another
“Dynamic State” Epidemiological Model of Microbial
Risk - Modeling Infectious Disease Dynamics and
Transmission in Populations
• Members of population move between states
– States describe status with respect to a pathogen
• Movement from state-to-state is modeled with ordinary differential equations;
– define rates of movement between states: rate terms
• Each transmission process is assumed to be independent
• Change in fraction of population in any state from one time period to another can be described and quantified
• Different sources of pathogen exposure can be identified and included in the model
“Dynamic State” Epidemiological Model of
Microbial Risk - State Variables
“SIR” Model of Infectious Disease
State Variables: track no. people in each state at a point in time
• S = susceptible = not infectious; not symptomatic
• I = Infected
– C = carrier = infectious; not symptomatic
– D = disease = infectious; symptomatic
• R = Resistant; same as P = post infection (or) not infectious; not symptomatic; short-term or partial immunity
• In epidemiology these states are called SIR
Infectious Disease Transmission Model at
the Population Level: Dynamic Model
• Risk estimation depends on transmission dynamics
and exposure pathways. Example: Water
“Dynamic State” Epidemiological Model
of Microbial Transmission and Disease Risk
Diseased ICarrier I
Susceptible
Post-infection
Predicted Waterborne Cryptosporidiosis in NYC in AIDS PatientsCompared to the General Population
Adults Children Adultswith AIDS
Pediatric AIDS
Total NYC population 6,080,000 1,360,000 30,000 1,200Reported cases (1995)
40 30 390 10
Predicted tapwater-related reported cases (%of total actually reported)
2 (5%) 3 (10%) 33 (8.5%) 1(10%)
Predicted annual riskfrom tapwater unreported(% of those predicted tobe reported)
5,400(0.03%)
940(0.3%)
56 (59%) 1 (100%)
Perz et al., 1998, Am. J. Epid., 147(3):289-301
Percent of Study Subjects Reporting HCGI Symptoms and Mean Number ofEpisodes per Unit of Observation in Both Periods Combined
Group
Filtered Water (n=272) Tap Water (n=262)
Unit ofObservation
% withEpisodesa
Mean Numberof Episodesb
% withEpisodes
Mean Numberof Episodes
Family 62.0 3.82 67.7 4.81
Informant 20.0 1.70 23.1 2.10
Youngestchild
42.3 1.83 46.3 2.37
aDerived by logistic regression with covariables age, sex, geographic sub-region.bMean number of episodes among those subjects who reported at least oneepisode.
Impacts of Household Water Quality on Gastrointestinal
Illness - Payment Study #1 (An Intervention Study)
Additional Analyses of Health Effects:Health Effects Assessments
• Health Outcomes of Microbial Infection
• Identification and diagnosis of disease caused by
the microbe
– disease (symptom complex and signs)
– Acute and chronic disease outcomes
– mortality
– diagnostic tests
• Sensitive populations and effects on them
• Disease Databases and Epidemiological Data
Methods to Diagnose Infectious Disease
• Symptoms (subjective: headache, pain) and
Signs (objective: fever, rash, diarrhea)
• Clinical diagnosis: lab tests
– Detect causative organism in clinical specimens
– Detect other specific factors associated with
infection
• Immune response
– Detect and assay antibodies
– Detect and assay other specific immune
responses
Health Outcomes of Microbial Infection
• Acute Outcomes
– Diarrhea, vomiting, rash, fever, etc.
• Chronic Outcomes
– Paralysis, hemorrhagic uremia, reactive
arthritis, etc.
• Hospitalizations
• Deaths
Morbidity Ratios for Salmonella (Non-typhi)
Study Population/Situation Morb. (%) 1 Children/food handlers 502 Restaurant outbreak 553 College residence outbreak 694 Nursing home employees 75 Hospital dietary personnel 86 " 67 Nosocomial outbreak 278 Summer camp outbreak 809 Nursing home outbreak 23
10 Nosocomial outbreak 4311 Foodborne outbreak 5412 Foodborne outbreak 66
Avg. 41
Acute and Chronic Outcomes Associated with
Microbial Infections
Microbe Acute Outcomes Chronic Outcomes
Campylobacter Diarrhea Guillain-Barre Syndrome
E. coli O157:H7 Diarrhea Hemolytic Uremic Syn.
Helicobacter Gastritis Ulcers & Stomach Cancer
Sal., Shig., Yer. Diarrhea Reactive arthritis
Coxsackie B3 Encephalitis, etc. Myocarditis & diabetes
Giardia Diarrhea Failure to thrive; joint pain
Toxoplasma NewbornSyndrome
Mental retardation,dementia, seizures
Outcomes of Infection Process to be Quantified
Hospitalization
Infection Asymptomatic Infection
Mortality
DiseaseAdvanced
Illness,
Chronic
Infections
and
Sequelae
Acute Symptomatic Illness:
Severity and Debilitation
Exposure
Sensitive Populations
Sensitive Populations
• Infants and young children
• Elderly
• Immunocompromized
– Persons with AIDs
– Cancer patients
– Transplant patients
• Pregnant
• Malnourished
Mortality Ratios for Enteric Pathogens in Nursing
Homes Versus General Population
Mortality Ratio (%) in:Microbe
General Pop. Nursing Home Pop.
Campylobacterjejuni
0.1 1.1
E. coli O157:H7 0.2 11.8
Salmonella 0.01 3.8
Rotavirus 0.01 1.0
Snow Mtn. Agent 0.01 1.3
Impact of Waterborne Outbreaks of Cryptosporidiosis
on AIDS Patients
Outbreak Attack Rate Mortal. Ratio (%)
Comments
Oxford/ Swindon, UK, 1989
36 Not repor- Ted
3 of 28 renal transplants pts. Shedding oocysts asymptomatically
Milwaukee, WI, 1993
45 68 17% biliary disease; CD4 counts <50 associated with high risks
Las Vegas, NV, 1994
Not known; incr. Crypto-+ stools
52.6 CD4 counts <100 at high risk; bottled water case-controls protective
Mortality Ratios Among Specific Immunocompromised
Patient Groups with Adenovirus Infection
Patient Group % Mortality (Case-Fatality Ratio)
Overall Mean Age of Patient Group (Yrs.)
Bone marow transplants
60 15.6
Renal transplant recipients
18 35.6
Cancer patients 53 25
AIDS patients 45 31.1
Databases for Quantification and Statistical
Assessment of Disease
• National Notifiable Disease Surveillance System
• National Ambulatory Medical Care Survey
• International Classification of Disease (ICD) Codes
• Other Databases
– Special surveys
– Sentinel surveillance efforts
Elements That May Be Considered in Risk
Characterization
• Evaluate health consequences of exposure scenario– Risk description (event)
– Risk estimation (magnitude, probability)
• Characterize uncertainty/variability/confidence in
estimates
• Conduct sensitivity analysis– evaluate most important variables and information needs
• Address items in problem formulation (reality check)
• Evaluate various control measures and their effects
on risk magnitude and profile
• Conduct decision analysis– evaluate alternative risk management strategies
Approaches for Risk Estimation: Risk Characterization Model
Cryptosporidium Giardia Viruses
1. Source water
Concentration (organisms per liter) (Normal Mean (SD)*)
1.06 (2.24)
2.68 (24.20)
0.93 (3.00)
Recovery rate 0.40 0.40 0.48
2. Treatment efficiency (logs removal)
Sedimentation and filtration (Mean (SD)*)
3.84 (0.59)
3.84 (0.59)
1.99 (0.52)
Chlorination (Mean (SD)
0 3.5 (2.93) 4 (2.93)
3. Water Consumption
in liters (mean (SD) ‡)
0.094 (0.42)
0.094 (0.42)
0.094 (0.42)
4. Dose Response § λ: 0.004078 λ:
0.01982 α,β: 0.26, 0.42
5. Morbidity Ratio# 0.39 0.40 0.57
Comparing Risks of Disease Agents
• Need to compare chemical to microbial risks as
well as among agents of each type
• Effects vary widely in severity, mortality rates
and time scale of exposure and effects
• Need to protect both quality and quantity of life
• Drinking water policy needs to be linked to
overall public health policy
• Decision making process needs to take social
and economic factors into account
Desirable attributes of an
integrated measure of risk• Address probability, nature, magnitude
and duration of adverse health consequences
• Incorporate age and health status of those affected
DALYs as unit measures
for health• Conceptually simple:
– health loss = N x D x S
• N = number of affected persons
• D = duration of adverse health effect
• S = measure for severity of the effect
• Disability Adjusted Life Years
– mortality: years of life lost (YLL)
– morbidity: years lived with disability (YLD)
– DALY = YLL + YLD
Hypothetical example
0
0.2
0.4
0.6
0.8
1
0 20 40 60 80
Age
Dis
ab
ilit
y w
eig
ht
Residual
disability
Premature
deathAcute
(infectious)
disease
Key Question: define health?
� ‘a state of complete physical, mental and social well-being, and not merely the absence of disease or infirmity’(WHO charter, 1946)
� ‘the ability to cope with the demands of daily life’ (the Dunning Committee on Medical Cure and Care, 1991)
� the absence of disease and other physical or psychological complaints (NSCGP, 1999)
Deriving severity weights
• Global Burden of Disease Project
– Define 22 indicator conditions
– Use Person Trade Off method to elicit
severity weights
– Panel of physicians and public health
scientists
– Use scale of indicator conditions to
attribute severity weights to other
conditions
– Methodology also applied in other studies